Existing users please login

Home / Markets / Industries / Health Care

Drug Stocks Advance; Cephalon Falls On Study

 
By Val Brickates Kennedy
MarketWatch Pulse
     

    BOSTON -- Drug stocks advanced substantially in early action Monday, echoing gains in the broader market, while shares of Cephalon Inc. fell on news that a later-stage clinical study for its pediatric drug Cinquil came up short-handed. The NYSE Arca Pharmaceutical Index jumped 1.8% to 308.86 and the NYSE Arca Biotechnology Index hopped 0.9% to 873.55. The Dow Jones Industrial Average rose almost 150 points to 10,464. Cephalon shares broke from the upward trend, sliding 8% to $54.98.

    Copyright © 2009 MarketWatch, Inc.

    Fox Business Video


    Last 5 Stocks

    • Ticker
    • Company
    • Price
    • Change